AORT vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

AORT

48.0
AI Score
VS
LUNG Wins

LUNG

49.6
AI Score

Investment Advisor Scores

AORT

48score
Recommendation
HOLD

LUNG

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AORT LUNG Winner
Revenue 242.09M 43.34M AORT
Net Income -12.09M -23.73M AORT
Gross Margin 64.4% 78.0% LUNG
Net Margin -5.0% -54.8% AORT
Operating Income -2.58M -22.01M AORT
ROE -2.7% -60.6% AORT
ROA -1.1% -20.7% AORT
Total Assets 1.07B 114.73M AORT
Cash 77.32M 55.84M AORT
Debt/Equity 0.82 0.96 AORT
Current Ratio 3.47 4.32 LUNG
Free Cash Flow -18.86M -15.32M LUNG

Relative Price Performance (Last 90 Days)

AORT 1M: -12.4% · 3M: +21.7% LUNG 1M: -19.2% · 3M: +30.3%

Current Technical Phase

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.6 · Price: $25.08

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.6 · Price: $1.85

Fundamentals Snapshot

Metric AORT LUNG
Market Cap
Forward P/E 33.5 -2.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% -0.4%
EPS -0.06 -1.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.